Nocardiosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

A new combination drug therapy (sulfonamide, ceftriaxone, and amikacin) has shown promise for treatment of infections not responding to standard antimicrobial treatments. Application of newer molecular diagnostic and subtyping methods may assist in earlier diagnosis.

Template:WH Template:WS